Skip Navigation

Journal of Antimicrobial Chemotherapy 2006 57(4):661-665; doi:10.1093/jac/dkl037
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Gray, K. J.
Right arrow Articles by Hart, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gray, K. J.
Right arrow Articles by Hart, C. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Identification and characterization of ceftriaxone resistance and extended-spectrum ß-lactamases in Malawian bacteraemic Enterobacteriaceae

Katherine J. Gray1,2,*, Lorna K. Wilson1, Amos Phiri1, John E. Corkill2, Neil French1,3 and C. Anthony Hart2

1 Malawi-Liverpool-Wellcome Trust Laboratories, PO Box 30096, Blantyre, Malawi; 2 Department of Medical Microbiology, Royal Liverpool University Hospital, Liverpool L7 8XP, UK; 3 Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UK

Received 8 November 2005; returned 20 November 2005; revised 20 January 2006; accepted 24 January 2006


* Corresponding author. Tel: +265-167-6444; Fax: +265-167-5774; E-mail: kgray{at}mlw.medcol.mw

Objectives: To enumerate and characterize extended-spectrum ß-lactamases (ESBLs) amongst ceftriaxone-resistant coliforms in Blantyre, Malawi, where third-generation cephalosporin use is currently highly restricted.

Methods: Over the period April 2004–March 2005 all ceftriaxone-resistant isolates from blood cultures were examined for the presence of ESBLs. Isoelectric focusing was performed on enzyme extracts. PCR and DNA sequencing of amplicons were used to identify the underlying genetic determinants responsible for the ESBL phenotypes. Transferability of the ESBL phenotypes was tested by conjugation to a susceptible Escherichia coli J53.

Results: Enterobacteriaceae were isolated from 1191 blood cultures, of which 19 (1.6%) were ceftriaxone resistant. Ten isolates (0.7% of all isolates) demonstrated an ESBL phenotype but only eight were characterized as three isolates were from the same patient. Genotypes SHV-11 (n = 1), SHV-12 (n = 3), SHV-27 (n = 1), TEM-63 (n = 2) and CTX-M-15 (n = 1) were detected. Plasmid transfer of the ESBL resistance phenotype was successful for all the isolates.

Conclusions: In a clinical setting of minimal cephalosporin usage there is already a diversity of ESBL genotypes. Increased use of cephalosporins in this setting is likely to result in a rapid expansion of ESBLs and their prevalence will need to be carefully monitored.

Keywords: molecular epidemiology , Africa , ESBLs


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
P. Kiratisin, A. Apisarnthanarak, C. Laesripa, and P. Saifon
Molecular Characterization and Epidemiology of Extended-Spectrum- {beta}-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Isolates Causing Health Care-Associated Infection in Thailand, Where the CTX-M Family Is Endemic
Antimicrob. Agents Chemother., August 1, 2008; 52(8): 2818 - 2824.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.